tocilizumab

Caring for the Patient with Cutaneous Immune-Related Events

Dr. Chen presented new research on the management of dermatologic immune-related adverse events (D-irAEs), including high-yield tips, and discussed potential future implications and therapeutic care of patients who receive immune checkpoint inhibitors (ICIs).